Annals of Oncology· @Annals_Oncology · X·· 2 天前评分70
正文 · 机器翻译
📢 #ESMO26 同期论文 - Capivasertib 联合 abiraterone 治疗 PTEN 缺失的初诊转移性激素敏感性前列腺癌：CAPItello-281 的更新生存分析。
🔗https://shorturl.at/c6tvw
@Daniel_J_George
1588 浏览 · 10 赞 · 4 转发 · 0 回复
会议摘要
Capivasertib (capi) + abiraterone (abi) vs placebo (pbo) + abi in patients (pts) with PTEN-deficient metastatic hormone-sensitive prostate cancer (mHSPC): Updated overall survival (OS) from CAPItello-281
https://esmocongress.esmo.org来源：Annals of Oncology · x.com